TP53 and neoplasm: After CAR T cells infusion, large amounts of tumor-derived ascites appeared, and FISH analysis found MYC, BCL2, and BCL6 (triple-hit) rearrangements with TP53 gene deletion (figure 1D) on day +81 (July 22, 2019).